Thursday, February 12, 2026 | 09:27 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Kilitch Drugs (India) consolidated net profit declines 25.67% in the December 2025 quarter

Sales decline 4.20% to Rs 53.81 crore

Net profit of Kilitch Drugs (India) declined 25.67% to Rs 4.43 crore in the quarter ended December 2025 as against Rs 5.96 crore during the previous quarter ended December 2024. Sales declined 4.20% to Rs 53.81 crore in the quarter ended December 2025 as against Rs 56.17 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var.Sales53.8156.17 -4 OPM %11.4315.54 -PBDT6.539.06 -28 PBT5.608.25 -32 NP4.435.96 -26

Powered by Capital Market - Live News

 

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Feb 12 2026 | 9:19 AM IST

Explore News